Krassimir Mitchev - Concepedia

Author

Krassimir Mitchev

UCB Pharma (Belgium)

Also Known As

K Mitchev, K. Mitchev, Krassimir Mitchev

Publications

526

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (Belgium)Imelda Hospital Centre Hospitalier Universitaire de Lille University of Miami University of Alberta

About

Krassimir Mitchev is an author at UCB Pharma (Belgium) specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	245
2	Gastroenterology	4	4	211
3	Immunology	2	2	173
4	Allergy	1	1	34
5	Allergy Medicine	1	1	34

Krassimir Mitchev

Publications

471

Citations

H-Index

Page 1

	Year	Citations
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol Xavier Hébuterne, Marc Lémann, Yoram Bouhnik, Gut	2012	165
Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab William J. Sandborn, María T. Abreu, Geert D’Haens, Clinical Gastroenterology and Hepatology InflammationSevere CrohnSecondary FailureImmunologyGastroenterology	2010	148
`Black Spots' and Hyaline Pleural Plaques on the Parietal Pleura of 150 Urban Necropsy Cases Krassimir Mitchev, Pascal Dumortier, Paul De Vuyst The American Journal of Surgical Pathology	2002	61
Non-Interventional Study Comparing Treatment Satisfaction in Patients Treated with Antihistamines Christine De Vos, Krassimir Mitchev, Marie-Etienne Pinelli, Clinical Drug Investigation AllergyPatients TreatedAllergy MedicineSymptomatic TreatmentOutcomes Research	2008	34
494 Efficacy and Safety of Certolizumab Pegol in Patients with Active Crohn's Disease Who Previously Lost Response or Were Intolerant to Infliximab: Open-Label Induction Preliminary Results of the Welcome Study Séverine Vermeire, María T. Abreu, Geert D’Haens, Gastroenterology Anti-inflammatoryActive CrohnImmunologyGastroenterologyWelcome Study	2008	25
Endoscopic Mucosal improvement in patients with active Crohnʼs Disease treated with Certolizumab Pegol J F Colombel, Marc Lémann, Y. Bouhnik, Inflammatory Bowel Diseases Endoscopic Mucosal ImprovementGastroenterologyPathologyActive Crohnʼs DiseaseSurgery	2008	24
S1045 Endoscopic Mucosal Improvement in Patients With Active Crohn's Disease Treated With Certolizumab Pegol: Week 10 and 54 Results of the Music Trial Jean–Frédéric Colombel, Marc Lémann, Yoram Bouhnik, Gastroenterology GastroenterologyClinical GastroenterologySurgeryMusic TrialUlcerative Colitis	2010	14

Page 1